Paul A. Sobotka

6.3k total citations · 2 hit papers
46 papers, 3.8k citations indexed

About

Paul A. Sobotka is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul A. Sobotka has authored 46 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul A. Sobotka's work include Blood Pressure and Hypertension Studies (27 papers), Heart Rate Variability and Autonomic Control (21 papers) and Cardiovascular Syncope and Autonomic Disorders (7 papers). Paul A. Sobotka is often cited by papers focused on Blood Pressure and Hypertension Studies (27 papers), Heart Rate Variability and Autonomic Control (21 papers) and Cardiovascular Syncope and Autonomic Disorders (7 papers). Paul A. Sobotka collaborates with scholars based in United States, Australia and Germany. Paul A. Sobotka's co-authors include Markus P. Schlaich, Henry Krum, Murray Esler, Michael Böhm, Horst Sievert, A. Walton, S. Thambar, Jerzy Sadowski, William T. Abraham and Krzysztof Bartuś and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Paul A. Sobotka

46 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

2009 1.4k citations Henry Krum, Markus P. Schlaich et al. The Lancet profile →
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension

2011 399 citations Felix Mahfoud, Markus P. Schlaich et al. Circulation profile →

Peers

Countries citing papers authored by Paul A. Sobotka

Since Specialization

Citations

This map shows the geographic impact of Paul A. Sobotka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Sobotka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Sobotka more than expected).

Fields of papers citing papers by Paul A. Sobotka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Sobotka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Sobotka. The network helps show where Paul A. Sobotka may publish in the future.

Co-authorship network of co-authors of Paul A. Sobotka

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Sobotka. A scholar is included among the top collaborators of Paul A. Sobotka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Sobotka. Paul A. Sobotka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Noninvasive System for Remote Monitoring of Left Ventricular Filling Pressures 2025 ·JACC Basic to Translational Science ·(unknown), (unknown), Nikola Jajcay, Amitai Segev, (unknown), Marta Kollárová, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Paul A. Sobotka, (unknown)	1
2	The Clinical Problem of Pelvic Venous Disorders 2022 ·Interventional Cardiology Clinics ·Abu Baker Sheikh, Marat Fudim, Ishan Garg, Abdul Mannan Khan Minhas, (unknown), Manesh R. Patel, Marvin H. Eng, Paul A. Sobotka	2
3	Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension 2017 ·Hypertension ·Melvin D. Lobo, Christian Ott, Paul A. Sobotka, Manish Saxena, Alice Stanton, John R. Cockcroft, Neil Sulke, Eamon Dolan, Markus van der Giet, Joachim Hoyer, Stephen Furniss, John P. Foran, Adam Witkowski, Andrzej Januszewicz, Danny Schoors, Konstantinos Tsioufis, Benno J. Rensing, Benjamin Scott, G. André Ng, Roland E. Schmieder	29
4	Unilateral Carotid Body Resection in Resistant Hypertension 2016 ·JACC Basic to Translational Science ·Krzysztof Narkiewicz, Laura E. Ratcliffe, Emma C. Hart, Linford J.B. Briant, Marzena Chrostowska, Jacek Wolf, Anna Szyndler, Dagmara Hering, Ana P. Abdala, Nathan Manghat, Amy E. Burchell, Claire Durant, Melvin D. Lobo, Paul A. Sobotka, Nikunj K. Patel, James C. Leiter, Zoar J. Engelman, Angus K. Nightingale, Julian F. R. Paton	120
5	Meta-Analysis of the Effect of Renal Denervation on Blood Pressure and Pulse Pressure in Patients With Resistant Systemic Hypertension 2014 ·The American Journal of Cardiology ·Samir Pancholy, Ghanshyam Palamaner Subash Shantha, Tejas Patel, Paul A. Sobotka, David E. Kandzari	19
6	Expanding the indication spectrum: renal denervation in diabetes 2013 ·EuroIntervention ·Felix Mahfoud, Sebastian Ewen, Christian Ukena, Dominik Linz, Paul A. Sobotka, Bodo Cremers, Michael Böhm	9
7	Renal nerve ablation reduces augmentation index in patients with resistant hypertension 2013 ·Journal of Hypertension ·Dagmara Hering, Élisabeth Lambert, Petra Marušić, Carolina Ika-Sari, Antony Walton, Henry Krum, Paul A. Sobotka, Felix Mahfoud, Michael Böhm, Gavin Lambert, Murray Esler, Markus P. Schlaich	55
8	Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension 2012 ·Circulation ·Murray Esler, Henry Krum, Markus P. Schlaich, Roland E. Schmieder, Michael Böhm, Paul A. Sobotka	325
9	LONG-TERM FOLLOW-UP OF CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION CONFIRMS DURABLE BLOOD PRESSURE REDUCTION 2012 ·Journal of the American College of Cardiology ·Henry Krum, Neil C. Barman, Markus P. Schlaich, Paul A. Sobotka, Murray Esler, Felix Mahfoud	15
10	RENAL SYMPATHETIC DENERVATION FOR TREATMENT OF RESISTANT HYPERTENSION: ONE YEAR RESULTS FROM THE SYMPLICITY HTN-2 RANDOMIZED CONTROLLED TRIAL 2012 ·Journal of the American College of Cardiology ·Murray Esler, Henry Krum, Markus P. Schlaich, Roland E. Schmieder, Michael Böhm, Paul A. Sobotka	5
11	Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea 2011 ·Hypertension ·Adam Witkowski, Aleksander Prejbisz, Elżbieta Florczak, Jacek Kądziela, Paweł Śliwiński, Przemysław Bieleń, Ilona Michałowska, Marek Kabat, Ewa Warchoł, Magdalena Januszewicz, Krzysztof Narkiewicz, Virend K. Somers, Paul A. Sobotka, Andrzej Januszewicz	330
12	Recent advances in the treatment of hypertension 2011 ·Expert Review of Cardiovascular Therapy ·Dagmara Hering, Murray Esler, Henry Krum, Felix Mahfoud, Michael Böhm, Paul A. Sobotka, Markus P. Schlaich	13
13	QUANTIFYING THE HAWTHORNE EFFECT: THE DIFFERENCE IN MORTALITY RATE OBSERVED IN THE CONTROL ARM OF CARDIOVASCULAR TRIALS CANNOT BE EXPLAINED BY PHARMACOLOGIC INTERVENTIONS 2011 ·Journal of the American College of Cardiology ·(unknown), David J. Bryg, Paul A. Sobotka, Robert J. Bryg	1
14	Renal Denervation and Hypertension 2011 ·American Journal of Hypertension ·Markus P. Schlaich, Henry Krum, Paul A. Sobotka, (unknown)	44
15	Sympatho-renal axis in chronic disease 2011 ·Clinical Research in Cardiology ·Paul A. Sobotka, Felix Mahfoud, Markus P. Schlaich, Uta C. Hoppe, Michael Böhm, Henry Krum	132
16	Renal denervation: a potential new treatment modality for polycystic ovary syndrome? 2011 ·Journal of Hypertension ·Markus P. Schlaich, Nora E. Straznicky, Mariee T. Grima, Carolina Ika-Sari, Tye Dawood, Felix Mahfoud, Élisabeth Lambert, Reena Chopra, Flora Socratous, Sarah C. Hennebry, Nina Eikelis, Michael Böhm, Henry Krum, Gavin Lambert, Murray Esler, Paul A. Sobotka	109
17	Renal Sympathetic Nerve Ablation: The New Frontier in the Treatment of Hypertension 2010 ·Current Hypertension Reports ·Markus P. Schlaich, Henry Krum, Paul A. Sobotka	36
18	Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study breakdown → 2009 ·The Lancet ·Henry Krum, Markus P. Schlaich, R. Whitbourn, Paul A. Sobotka, Jerzy Sadowski, Krzysztof Bartuś, Bogusław Kapelak, A. Walton, Horst Sievert, S. Thambar, William T. Abraham, Murray Esler	1388
19	Nutrition in Acute Pulmonary Disease 2009 ·Nutrition Reviews ·Mark T. DeMeo, (unknown), Klaus Gottlieb, Paul A. Sobotka, Sohrab Mobarhan	1
20	Reply 2006 ·Journal of the American College of Cardiology ·Maria Rosa Costanzo, Paul A. Sobotka	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact